Solvent ‘may raise cancer risk for women’
New research showed that the chemical, ethylene glycol methyl ether (EGME), boosted the activity of hormones used in the treatments by up to 10 times.
This would increase the danger for women threatened by hormone-sensitive breast and ovarian cancers, triggered by the action of oestrogen or progesterone.